These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27795699)

  • 1. Isozymes of AMP-Deaminase in Muscles Myasthenia Gravis Patients.
    Rybakowska IM; Bakuła S; Kaletha K
    Int J Pept Res Ther; 2016; 22(4):511-515. PubMed ID: 27795699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP-deaminase from thymus of patients with myasthenia gravis.
    Rybakowska I; Szydłowska M; Szrok S; Bakuła S; Kaletha K
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(3):229-34. PubMed ID: 25710358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myoadenylate deaminase deficiency among patients with myasthenia gravis--preliminary results of exercise].
    Bilińska M; Chodorowski Z; Nyka W; Nyka W; Rybakowska I; Smoleński R; Kaletha K
    Przegl Lek; 2003; 60(11):724-5. PubMed ID: 15058043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [AMPD genes and urate metabolism].
    Morisaki H; Morisaki T
    Nihon Rinsho; 2008 Apr; 66(4):771-7. PubMed ID: 18409530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology of AMP deaminase deficiency.
    Gross M
    Pharm World Sci; 1994 Apr; 16(2):55-61. PubMed ID: 8032342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity.
    Sabbatini AR; Toscano A; Aguennouz M; Martini D; Polizzi E; Ranieri-Raggi M; Moir AJ; Migliorato A; Musumeci O; Vita G; Raggi A
    J Muscle Res Cell Motil; 2006; 27(1):83-92. PubMed ID: 16570231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic evidence for three isoforms of AMP deaminase (AMPD) in mature skeletal muscle.
    Fishbein WN; Sabina RL; Ogasawara N; Holmes EW
    Biochim Biophys Acta; 1993 Apr; 1163(1):97-104. PubMed ID: 8476935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of AMP deaminase deficiency in skeletal muscle.
    Morisaki T; Gross M; Morisaki H; Pongratz D; Zöllner N; Holmes EW
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6457-61. PubMed ID: 1631143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoadenylate deaminase deficiency studies on normal and deaminase-deficient skeletal muscle.
    Kaletha K; Nowak G
    Clin Chim Acta; 1990 Oct; 190(3):147-55. PubMed ID: 2253394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and immunologic evidence for a complete gene block in myoadenylate deaminase deficiency.
    Fishbein WN; Davis JI; Foellmer JW
    J Exp Pathol; 1983; 1(1):7-25. PubMed ID: 6086015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
    Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
    BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolocalization of AMP-deaminase isozymes in human skeletal muscle and cultured muscle cells: concentration of isoform M at the neuromuscular junction.
    van Kuppevelt TH; Veerkamp JH; Fishbein WN; Ogasawara N; Sabina RL
    J Histochem Cytochem; 1994 Jul; 42(7):861-8. PubMed ID: 8014469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and expression of cDNA encoding heart-type isoform of AMP deaminase.
    Wang X; Morisaki H; Sermsuvitayawong K; Mineo I; Toyama K; Ogasawara N; Mukai T; Morisaki T
    Gene; 1997 Apr; 188(2):285-90. PubMed ID: 9133604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.
    Tarnopolsky MA; Parise G; Gibala MJ; Graham TE; Rush JW
    J Physiol; 2001 Jun; 533(Pt 3):881-9. PubMed ID: 11410643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for sequential expression of multiple AMP deaminase isoforms during skeletal muscle development.
    Marquetant R; Desai NM; Sabina RL; Holmes EW
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2345-9. PubMed ID: 3470799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle.
    Plaideau C; Lai YC; Kviklyte S; Zanou N; Löfgren L; Andersén H; Vertommen D; Gailly P; Hue L; Bohlooly-Y M; Hallén S; Rider MH
    Chem Biol; 2014 Nov; 21(11):1497-1510. PubMed ID: 25459662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance.
    Hanisch F; Joshi P; Zierz S
    J Neurol; 2008 Mar; 255(3):318-22. PubMed ID: 18338202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of isolated AMP deaminase deficiency on skeletal muscle function.
    Cheng J; Morisaki H; Sugimoto N; Dohi A; Shintani T; Kimura E; Toyama K; Ikawa M; Okabe M; Higuchi I; Matsuo S; Kawai Y; Hisatome I; Sugama T; Holmes EW; Morisaki T
    Mol Genet Metab Rep; 2014; 1():51-59. PubMed ID: 27896074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoadenylate deaminase deficiency with progressive muscle weakness and atrophy caused by new missense mutations in AMPD1 gene: case report in a Japanese patient.
    Abe M; Higuchi I; Morisaki H; Morisaki T; Osame M
    Neuromuscul Disord; 2000 Oct; 10(7):472-7. PubMed ID: 10996775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental forms of human skeletal-muscle AMP deaminase. The kinetic and regulatory properties of the enzyme.
    Kaletha K; Nowak G
    Biochem J; 1988 Jan; 249(1):255-61. PubMed ID: 3342010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.